Breaking News Instant updates and real-time market news.

CLF

Cleveland-Cliffs

$11.79

0.9 (8.26%)

, VALE

Vale

$11.45

0.285 (2.55%)

15:41
02/08/19
02/08
15:41
02/08/19
15:41

Cleveland-Cliffs CEO expects 'big jumps' in iron ore pellet prices on Monday

Cleveland-Cliffs (CLF) CEO Lourenco Goncalves, speaking about iron ore prices in the wake of the dam accident suffered by Vale (VALE), said he expects "big jumps" in prices for the underlying commodity and in pellet prices on Monday when China returns to the market after the country's New Year holiday. Goncalves is being interviewed on CNBC.

CLF

Cleveland-Cliffs

$11.79

0.9 (8.26%)

VALE

Vale

$11.45

0.285 (2.55%)

  • 08

    Feb

  • 08

    Feb

CLF Cleveland-Cliffs
$11.79

0.9 (8.26%)

01/08/19
COWN
01/08/19
INITIATION
Target $8.5
COWN
Market Perform
Cleveland-Cliffs initiated with a Market Perform at Cowen
Cowen analyst Tyler Kenyon initiated Cleveland-Cliffs with a Neutral and $8.50 price target.
01/22/19
JEFF
01/22/19
DOWNGRADE
Target $24
JEFF
Hold
Jefferies downgrades U.S. Steel to Hold on guidance risk
Jefferies analyst Seth Rosenfeld downgraded U.S. Steel to Hold from Buy and lowered his price target for the shares to $24 from $38. "Poor" Q4 earnings and Q1 guides will begin to reflect the extent of recent steel margin weakness, Rosenfeld tells investors in a research note. The analyst, while remaining "constructive" on the broader Steel sector, downgraded U.S. Steel to reflect guidance risk and "increasingly challenged" long-term prospects. With both U.S. and European flat steel margins drifting lower, drivers for a "meaningful recovery" at the company are "hard to identify," says the analyst. As such, he believes U.S. Steel's 2019 EBITDA guidance risks disappointing consensus expectations. Rosenfeld's top picks in the U.S. are Nucor (NUE), Commercial Metals (CMC), Steel Dynamics (STLD), Reliance Steel (RS) and Cleveland-Cliffs (CLF).
02/08/19
SBSH
02/08/19
NO CHANGE
Target $13
SBSH
Buy
Cleveland-Cliffs price target raised to $13 from $10 at Citi
Citi analyst Alexander Hacking raised his price target for Cleveland-Cliffs to $13 to reflect his firm's higher iron ore price forecasts. Cleveland-Cliffs is expected to generate "materially higher" free cash flow in 2019 through 2022, Hacking tells investors in a research note. He keeps a Buy rating on the shares.
02/08/19
JEFF
02/08/19
NO CHANGE
JEFF
Cleveland-Cliffs price target raised to $13.75 from $11.50 at Jefferies
Jefferies analyst Seth Rosenfeld reiterated a Buy rating on Cleveland-Cliffs, and raised his price target to $13.75 from $11.50, after the company's Q4 earnings report. While the analyst noted that the results "disappointed," the company's "leverage to the reflating steel, iron ore and pellet markets continues to impress." Rosenfeld added that "with a near stranglehold on regional pellet supply," Cleveland-Cliffs "should secure improved contract terms post-2020 as supply tightens."
VALE Vale
$11.45

0.285 (2.55%)

02/05/19
BOFA
02/05/19
INITIATION
Target $13
BOFA
Neutral
Vale resumed with a Neutral at BofA/Merrill
BofA/Merrill resumed Vale with a Neutral and $13 price target.
02/07/19
MSCO
02/07/19
DOWNGRADE
MSCO
Equal Weight
Vale downgraded to Equal Weight from Overweight at Morgan Stanley
02/07/19
JPMS
02/07/19
NO CHANGE
Target $17
JPMS
Overweight
JPMorgan continues to see value in shares of Vale
More negative headlines, including the Minas Gerais environmental authorities cancelling the license of the Laranjeiras dam, drove shares of Vale down 5% yesterday, JPMorgan analyst Rodolfo Angele tells investors in a research note. The analyst says that while "it will be a bumpy ride as news flow should continue to emerge," he continues to see value in shares and maintains an Overweight rating. To reflect his firm's upgrade of iron ore prices earlier this week Angele raised his price target for Vale shares to $17 from $16.50.
02/07/19
02/07/19
DOWNGRADE

Equal Weight
Vale downgraded on continued uncertainty after dam accident at Morgan Stanley
As previously reported, Morgan Stanley analyst Carlos De Alba downgraded Vale to Equal Weight from Overweight and removed his price target on the stock citing the continued uncertainty following the tragic Feijao dam accident. An event of this magnitude is likely to create an overhang on the stock's multiple given the reputational uncertainty and heightened environmental risk, a lack of clarity on the ultimate financial ramifications and higher costs due to increased safety standards, De Alba tells investors.

TODAY'S FREE FLY STORIES

AMD

AMD

$33.59

-0.23 (-0.68%)

, INTC

Intel

$49.39

0.22 (0.45%)

04:59
07/18/19
07/18
04:59
07/18/19
04:59
Downgrade
AMD downgraded to Neutral from Buy at Mizuho »

Mizuho analyst Vijay…

AMD

AMD

$33.59

-0.23 (-0.68%)

INTC

Intel

$49.39

0.22 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 7/13 Jobless…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

GMRE

Global Medical REIT

$10.51

-0.15 (-1.41%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Global Medical REIT management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

TORC

ResTORbio

$10.42

0.19 (1.86%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
ResTORbio management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SUPV

Grupo Supervielle

$8.12

0.13 (1.63%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Grupo Supervielle management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Philadelphia Fed Business Outlook Survey General Conditions Index to be reported at 08:30 »

July Philadelphia Fed…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Leading Indicators to be reported at 10:00 »

June Leading Indicators…

CAMP

CalAmp

$10.82

-0.46 (-4.08%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
CalAmp participates in a conference call with Northland »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 06

    Aug

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

Week of 7/12 EIA Natural…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

4-Week Bill Auction to be…

CASY

Casey's General Stores

$160.43

0.08 (0.05%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Casey's General Stores management to meet with Northcoast »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 13

    Nov

OPNT

Opiant Pharmaceuticals

$13.24

-0.25 (-1.85%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Opiant Pharmaceuticals management to meet with Northland »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

ACAD

Acadia

$25.56

-0.72 (-2.74%)

, BIIB

Biogen

$229.39

-2.17 (-0.94%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Alzheimer's Association to hold a conference »

Alzheimer's…

ACAD

Acadia

$25.56

-0.72 (-2.74%)

BIIB

Biogen

$229.39

-2.17 (-0.94%)

CRL

Charles River

$135.30

0.08 (0.06%)

DGX

Quest Diagnostics

$100.18

-1.28 (-1.26%)

ESALY

Eisai

$0.00

(0.00%)

PKI

PerkinElmer

$95.10

-0.24 (-0.25%)

RHHBY

Roche

$0.00

(0.00%)

MRK

Merck

$81.93

0.36 (0.44%)

NSTG

NanoString

$30.44

-0.06 (-0.20%)

PRAH

PRA Health

$98.05

-0.43 (-0.44%)

QTRX

Quanterix

$31.45

0.37 (1.19%)

SYNH

Syneos Health

$47.64

-1.07 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 31

    Jul

  • 31

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 13

    Sep

  • 16

    Sep

  • 20

    Sep

  • 02

    Oct

  • 04

    Nov

CGC

Canopy Growth

$36.57

1.015 (2.85%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Canopy Growth management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
The Brookings Institution to hold a conference on the US-China Trade War »

The Global Economy &…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
House Judiciary Committee to hold a hearing »

The Subcommittee on…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

8-Week Bill Auction to be…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

Week of 7/17 Fed Balance…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

UBSFY

Ubisoft

$0.00

(0.00%)

, TTWO

Take-Two

$117.64

0.15 (0.13%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

UBSFY

Ubisoft

$0.00

(0.00%)

TTWO

Take-Two

$117.64

0.15 (0.13%)

NTDOY

Nintendo

$0.00

(0.00%)

GME

GameStop

$4.39

-0.245 (-5.29%)

EA

Electronic Arts

$89.72

0.15 (0.17%)

ATVI

Activision Blizzard

$46.69

-0.29 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 30

    Jul

  • 05

    Aug

  • 08

    Aug

  • 08

    Aug

  • 05

    Sep

  • 13

    Nov

GLMD

Galmed

$6.30

-0.2 (-3.08%)

, CBAY

CymaBay

$6.39

-0.15 (-2.29%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Cantor Fitzgerald biotech analysts to hold a KOL luncheon meeting »

Biotech Analysts Young…

GLMD

Galmed

$6.30

-0.2 (-3.08%)

CBAY

CymaBay

$6.39

-0.15 (-2.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
William Blair enterprise & cloud infrastructure analyst to hold a group luncheon »

Enterprise & Cloud…

DOVA

Dova Pharmaceuticals

$16.01

-0.06 (-0.37%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Dova Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Piper Jaffray to hold a conference »

BioInsights KOL Series…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.